{"url":"https://lda.senate.gov/api/v1/filings/3a4ec9ee-4d64-4754-aa81-29a67d30fc27/","filing_uuid":"3a4ec9ee-4d64-4754-aa81-29a67d30fc27","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2019,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/3a4ec9ee-4d64-4754-aa81-29a67d30fc27/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Danny McNamara","dt_posted":"2019-12-06T13:01:19.957000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Thirteenth Street, NW","registrant_address_2":"Eleventh Floor South","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":5357,"url":"https://lda.senate.gov/api/v1/registrants/5357/","house_registrant_id":31564,"name":"BGR GOVERNMENT AFFAIRS","description":"Lobbying firm","address_1":"601 13th Street, NW","address_2":"11th Floor South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHELSEA MINCHEFF","contact_telephone":"+1 202-661-6385","dt_updated":"2026-07-30T12:12:37.308899-04:00"},"client":{"id":106632,"url":"https://lda.senate.gov/api/v1/clients/106632/","client_id":1006385,"name":"ZOGENIX, INC.","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-01-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Zogenix specifically.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23860,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"WOOD","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":62729,"prefix":null,"prefix_display":null,"first_name":"BRENT","nickname":null,"middle_name":"ALAN","last_name":"DEL MONTE","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":65427,"prefix":null,"prefix_display":null,"first_name":"ROBB","nickname":null,"middle_name":null,"last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":69170,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"HOFFMANN","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":67545,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":143823,"prefix":"ms","prefix_display":"MS.","first_name":"REMY","nickname":null,"middle_name":"LEIGH BRIM","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}